Kun Li - Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Peking Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Endocrine Therapy Plus HER2-targeted Therapy, Another Favorable Option for HR+/HER2+ Advanced Breast Cancer Patients

Yuehua Liang,Xiaoran Liu,Zehui Yun,Kun Li,Huiping Li

Therapeutic Advances in Medical Oncology (2024)

引用0浏览0WOS引用

Men's Symptom Experience Throughout Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Aggregation

Siyuan Wu,Kun Li,Yin Zhang, Lijuan Wang,Binbin Zhu,Wei Wang

International journal of nursing studies (2024): 104796-104796

引用0浏览0WOS引用

Persistence of Peripheral CD8 + CD28− T Cells Indicates a Favourable Outcome and Tumour Immunity in First-Line HER2-positive Metastatic Breast Cancer

Xiaoran Liu, Xiangming Cheng,Feng Xie,Kun Li, Yongcan Shi,Bin Shao,Xu Liang,Fengling Wan,Shidong Jia,Yue Zhang,Yiqiang Liu,Huiping Li

BRITISH JOURNAL OF CANCERno. 10 (2024): 1599-1608

引用0浏览0WOSNATURE引用

A Phase 1 Trial of Fuzuloparib in Combination with Apatinib for Advanced Ovarian and Triple-Negative Breast Cancer: Efficacy, Safety, Pharmacokinetics and Germline BRCA Mutation Analysis

Yaxin Liu,Wei Wang,Rutie Yin,Youzhong Zhang,Yu Zhang,Keqiang Zhang,Hongming Pan,Ke Wang,Ge Lou,Guiling Li,Ruyan Zhang,Kun Li, Jing Rao,Ben Zhang,Yuting Wang,Quanren Wang,Yunong Gao,Huiping Li

BMC Medicineno. 1 (2023)

引用0浏览0WOS引用

Current Situation of Programmed Cell Death Protein 1/programmed Cell Death Ligand 1 Inhibitors in Advanced Triple-Negative Breast Cancer

Yuehua Liang,Xiaoran Liu,Kun Li,Huiping Li

Chinese Journal of Cancer Research（2022）

引用0浏览0WOS引用

Peripheral CD8+CD28- T Cell Level Reflects Tumor Immunity and Could Predict Anti- HER2 Based Therapy Response in Metastatic Breast Cancer

Huiping Li,Xiaoran Liu, Xiang-Ming Cheng,Feng Xie,Kun Li, Yong-Can Shi,Bin Shao,Xu Liang, Fang Wan,Yiqiang Liu

Research Square (Research Square) (2022)

引用0浏览0引用

Multicenter Phase II Study of Apatinib Single or Combination Therapy in HER2-negative Breast Cancer Involving Chest Wall Metastasis

Huiping Li,Cuizhi Geng,Hongmei Zhao,Hanfang Jiang,Guohong Song,Jiayang Zhang,Yaxin Liu,Xinyu Gui,Jing Wang,Kun Li,Zhongsheng Tong,Fangyuan Zhao,Junlan Yang, Guoliang Chen, Qianyu Liu,Xu Liang

Chinese Journal of Cancer Research（2021）

引用8浏览0WOS引用

Bilateral Breast Cancer in China: A 10‐year Single‐center Retrospective Study (2006–2016)

Hanfang Jiang,Ruyan Zhang,Xiaoran Liu, Ran,Jiayang Zhang,Yaxin Liu,Xinyu Gui,Yifei Chen,Kun Li,Bin Shao,Ying Yan,Xu Liang,Guohong Song,Lijun Di,Huiping Li

Cancer Medicine（2021）

引用4浏览0WOS引用

Efficacy Of Platinum-Based Regimens As The First-Line Therapy In Chinese Patients With Advanced Tnbc And Deleterious Brca1/2 Mutations

Nan Wang,Kun Li,Wei-Yao Kong,Xiao-Ran Liu,Meng-Yao Tan,Han-Fang Jiang,Guo-Hong Song,Lijun Di,Quanren Wang,Amy Wang,Jianjun Yu,Shidong Jia,Huiping Li

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn